Last reviewed · How we verify
NCT03615716
A Multi-level Approach to Violence Prevention Among African American Adolescents
NA trial testing Multi-level Violence Prevention Intervention - Boys in Violence in Adolescence in 32 participants. Completed in 12 June 2019.
12 June 2019
Quick facts
| Lead sponsor | University of Alabama at Birmingham |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 32 |
| Start date | 11 February 2019 |
| Primary completion | 12 June 2019 |
| Estimated completion | 12 June 2019 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Multi-level Violence Prevention Intervention - Boys
- Multi-level Violence Prevention Intervention - Caregivers
Conditions studied
- Violence in Adolescence — all drugs for Violence in Adolescence →
Sponsor
University of Alabama at Birmingham
Who can join
Adults 11 to 14, male only, with Violence in Adolescence. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The overall goal of this study is to advance the science of youth violence prevention and the social determinants of health by using a community-driven approach to implement a comprehensive intervention. The objective of the proposed project is to assess the feasibility, acceptability, and preliminary efficacy of an innovative, multi-level intervention that promotes adolescent protective factors and reduces risk behaviors among African American youth residing in Birmingham. Alabama.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03615716
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Violence in Adolescence
Currently open trials in the same condition.
- NCT06309134 — The Healthy Families Bright Futures Program · NA · recruiting
- NCT05768217 — Community Resiliency Collective Efficacy Intervention · NA · recruiting
- NCT06359990 — BrotherlyACT: A Tech-Enhanced Violence and Substance Use Intervention for Black Boys and Young Men · NA · active not recruiting
- NCT05743478 — Forging Hopeful Futures to Reduce Youth Violence · NA · active not recruiting
- NCT04850274 — Using Re-inforcement Learning to Automatically Adapt a Remote Therapy Intervention (RTI) for Reducing Adolescent Violenc · NA · active not recruiting
Other University of Alabama at Birmingham trials
Trials by the same sponsor.
- NCT04922229 — Comparative Effectiveness in the Management of Irreversible Pulpitis · NA · not yet recruiting
- NCT05060380 — Feasibility of a Novel Resistance Exercise in Individuals With Osteoporosis · NA · withdrawn
- NCT04768777 — Behavioral Intervention for Physical Activity and Sexual Dysfunction in Multiple Sclerosis · NA · not yet recruiting
- NCT06320951 — VITAL-IMPACT: Improving Cardiometabolic Health in Black Individuals Through Therapeutic Augmentation of Cyclic Guanosine · Phase 2 · not yet recruiting
- NCT07564934 — Leveraging Extended Reality Exergaming and Telehealth to Improve Physical Activity and Health in Children With Disabilit · Phase 2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03615716 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Alabama at Birmingham
- Last refreshed: 5 August 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03615716.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing